Moligo Technologies is at the forefront of enabling the next generation of DNA based tools. With a mission to push the limits of what is possible in genome editing, they specialize in producing ultrapure DNA strands that are over 10,000 bases long and 100% sequence verified. This ensures the best tools for improved precision and reduced off-target effects. Moligo's technology also allows for DNA with any modifications or complexity, removing limitations for researchers and pharmaceutical companies.

One key advantage of Moligo Technologies is their ability to produce DNA at scale. Unlike other methods, their technology allows them to produce kilograms of DNA, making them an ideal partner for large experiments and clinical trials.

Led by a team of experts in the field, including CEO and Founder Cosimo Ducani and Chairman of the Board Lech Ignatowicz, Moligo Technologies is committed to providing innovative solutions in the DNA space. With locations in Solna, Sweden, and Palo Alto, California, they are revolutionizing the field of genome editing on a global scale.